174 related articles for article (PubMed ID: 33333151)
1. Performance of Salamanca refinement of the T3-AJCC8 versus the Brigham and Women's Hospital and Tübingen alternative staging systems for high-risk cutaneous squamous cell carcinoma.
Puebla-Tornero L; Corchete-Sánchez LA; Conde-Ferreirós A; García-Sancha N; Corchado-Cobos R; Román-Curto C; Cañueto J
J Am Acad Dermatol; 2021 Apr; 84(4):938-945. PubMed ID: 33333151
[TBL] [Abstract][Full Text] [Related]
2. Comparing the eighth and the seventh editions of the American Joint Committee on Cancer staging system and the Brigham and Women's Hospital alternative staging system for cutaneous squamous cell carcinoma: Implications for clinical practice.
Cañueto J; Burguillo J; Moyano-Bueno D; Viñolas-Cuadros A; Conde-Ferreirós A; Corchete-Sánchez LA; Pérez-Losada J; Román-Curto C
J Am Acad Dermatol; 2019 Jan; 80(1):106-113.e2. PubMed ID: 30003984
[TBL] [Abstract][Full Text] [Related]
3. Validation of four cutaneous squamous cell carcinoma staging systems using nationwide data.
Venables ZC; Tokez S; Hollestein LM; Mooyaart AL; van den Bos RR; Rous B; Leigh IM; Nijsten T; Wakkee M
Br J Dermatol; 2022 May; 186(5):835-842. PubMed ID: 34862598
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma.
Karia PS; Jambusaria-Pahlajani A; Harrington DP; Murphy GF; Qureshi AA; Schmults CD
J Clin Oncol; 2014 Feb; 32(4):327-34. PubMed ID: 24366933
[TBL] [Abstract][Full Text] [Related]
5. Stratification of Poor Outcomes for Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients Using the American Joint Committee on Cancer Eighth Edition and Brigham and Women's Hospital Staging Systems.
Blechman AB; Carucci JA; Stevenson ML
Dermatol Surg; 2019 Sep; 45(9):1117-1124. PubMed ID: 30640779
[TBL] [Abstract][Full Text] [Related]
6. Comparison of tumor staging systems for cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia.
Inda JJ; Kabat BF; Larson MC; Slager SL; Baum CL
J Am Acad Dermatol; 2019 Mar; 80(3):639-645. PubMed ID: 30165169
[TBL] [Abstract][Full Text] [Related]
7. Performance of Staging Systems for Non-Head and Neck Cutaneous Squamous Cell Carcinoma.
Guerra R; Shahwan KT; Nikahd M; Hyer M; Carr DR
Dermatol Surg; 2024 Feb; 50(2):121-124. PubMed ID: 37962141
[TBL] [Abstract][Full Text] [Related]
8. Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women's Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma.
Ruiz ES; Karia PS; Besaw R; Schmults CD
JAMA Dermatol; 2019 Jul; 155(7):819-825. PubMed ID: 30969315
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study.
Tschetter AJ; Campoli MR; Zitelli JA; Brodland DG
J Am Acad Dermatol; 2020 Jan; 82(1):139-148. PubMed ID: 31279037
[TBL] [Abstract][Full Text] [Related]
10. Definition of prognostic subgroups in the T3 stage of the eighth edition of the American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: Tentative T3 stage subclassification.
Conde-Ferreirós A; Corchete LA; Puebla-Tornero L; Corchado-Cobos R; García-Sancha N; Román-Curto C; Cañueto J
J Am Acad Dermatol; 2021 Nov; 85(5):1168-1177. PubMed ID: 32278798
[TBL] [Abstract][Full Text] [Related]
11. Predictive Value of Sentinel Lymph Node Biopsy in Cutaneous Squamous Cell Carcinoma Based on the AJCC-8 and Brigham and Women's Hospital Staging Criteria.
Tejera-Vaquerizo A; Cañueto J; Llombart B; Martorell-Calatayud A; Sanmartín O
Dermatol Surg; 2020 Jul; 46(7):857-862. PubMed ID: 31567487
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the American Joint Committee on Cancer Seventh Edition and Brigham and Women's Hospital Cutaneous Squamous Cell Carcinoma Tumor Staging in Immunosuppressed Patients.
Gonzalez JL; Cunningham K; Silverman R; Madan E; Nguyen BM
Dermatol Surg; 2017 Jun; 43(6):784-791. PubMed ID: 28079640
[TBL] [Abstract][Full Text] [Related]
13. Brigham and Women's Hospital tumor classification system for basal cell carcinoma identifies patients with risk of metastasis and death.
Morgan FC; Ruiz ES; Karia PS; Besaw RJ; Neel VA; Schmults CD
J Am Acad Dermatol; 2021 Sep; 85(3):582-587. PubMed ID: 33497751
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Tumor Staging: Predicting Nodal Metastases in Cutaneous Squamous Cell Carcinoma.
Upton M; Kita A; Scapa J; St John M
Laryngoscope; 2021 Jan; 131(1):E170-E175. PubMed ID: 32212346
[TBL] [Abstract][Full Text] [Related]
15. Validating 4 Staging Systems for Cutaneous Squamous Cell Carcinoma Using Population-Based Data: A Nested Case-Control Study.
Roscher I; Falk RS; Vos L; Clausen OPF; Helsing P; Gjersvik P; Robsahm TE
JAMA Dermatol; 2018 Apr; 154(4):428-434. PubMed ID: 29516080
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of the 8th edition American Joint Commission Cancer nodal staging system for patients with head and neck cutaneous squamous cell carcinoma: A multi-institutional study.
Luk PP; Ebrahimi A; Veness MJ; McDowell L; Magarey M; Gao K; Palme CE; Clark JR; Gupta R
Head Neck; 2021 Feb; 43(2):558-567. PubMed ID: 33118253
[TBL] [Abstract][Full Text] [Related]
17. A critical analysis of the prognostic performance of the 8th edition American Joint Committee on Cancer staging for metastatic cutaneous squamous cell carcinoma of the head and neck.
Sood A; Wykes J; Roshan D; Wang LY; McGuinness J; Fowler A; Ebrahimi A
Head Neck; 2019 Jun; 41(6):1591-1596. PubMed ID: 30659690
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of the 8th edition American Joint Commission Cancer (AJCC) nodal staging system for patients with cutaneous squamous cell carcinoma of the head and neck.
Liu J; Ebrahimi A; Low TH; Gao K; Palme CE; Sydney C; Ashford BG; Iyer NG; Clark JR; Gupta R
J Surg Oncol; 2018 Mar; 117(4):765-772. PubMed ID: 29049841
[TBL] [Abstract][Full Text] [Related]
19. Major prognostic factors for recurrence and survival independent of the American Joint Committee on Cancer eighth edition staging system in patients with cutaneous squamous cell carcinoma treated with multimodality therapy.
Xu MJ; Lazar AA; Garsa AA; Arron ST; Ryan WR; El-Sayed IH; George JR; Algazi AP; Heaton CM; Ha PK; Yom SS
Head Neck; 2018 Jul; 40(7):1406-1414. PubMed ID: 29524273
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the eighth edition of the TNM and Brigham Women's Hospital staging systems for cutaneous squamous cell carcinoma of the head and neck: a six-year review.
Bowe CM; Houlton S; Walsh S
Br J Oral Maxillofac Surg; 2020 Nov; 58(9):1158-1163. PubMed ID: 33071049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
